CliffBio
small molecule

PHYTONADIONE

PHYTONADIONE

Loss of exclusivity—loss of exclusivity
CompanyCipla →See this company's full patent-cliff portfolio

Drug detail

Brand namePHYTONADIONE
Active ingredientPHYTONADIONE
Strength1MG/0.5ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJanuary 2025
Marketing statusRX

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PHYTONADIONE patent cliff — loss of exclusivity — | CliffBio